The study found that T cells recognize brain proteins and recruit resident immune cells to fight off toxic substances, enabling neurogenic regions like the hippocampus to form new nerve cells. This process is linked to local immune activity and may play a role in maintaining learning and memory abilities in adulthood.
SourceAmerican Committee for the Weizmann Institute of Science·JournalNature Neuroscience·DateJan 15, 2006
A new way to stimulate the brain to release antioxidants has been discovered by researchers, potentially treating ischemic stroke, multiple sclerosis, and neurodegenerative disorders. The NEPPs compound activates the Keap1/Nrf2 pathway to regulate antioxidant production, offering a promising approach for neuroprotection.
SourceSanford Burnham Prebys·JournalProceedings of the National Academy of Sciences·DateJan 9, 2006
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers found that exercise combined with gene therapy significantly extended the lifespan of mice with ALS, averaging 210 days, compared to 120 days in untreated mice. Early exercise initiation also improved outcomes, suggesting a potential strategy for slowing disease progression.
The Squid Genome Project aims to identify genes in squid that are essential for understanding debilitating neurological diseases. Researchers hope that this information will aid in the development of new treatments and therapies.
The AAN Foundation and ALS Association are partnering to provide funding for a Clinician Scientist Development Award in support of ALS research. The award aims to prioritize promising compounds for clinical trials, bringing hope to patients suffering from this debilitating disease.
Researchers found that riluzole, a glutamate modulating agent, reduced symptoms in 35% of patients with OCD. The study suggests that riluzole may represent a novel treatment intervention for certain anxiety and mood disorders.
SourceYale University·JournalBiological Psychiatry·DateJul 29, 2005
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
Researchers at Johns Hopkins Medicine have identified two proteins that help replace calcium-allowing channels with ones that keep calcium out, potentially protecting nerve cells from Lou Gehrig's disease. The discovery may lead to new ways to harness the channel-changing ability in other brain cells.
Researchers have found that 47% of ALS patients exhibit reverse transcriptase activity, suggesting a potential link to retroviruses. Further study is needed to determine if this reflects activation of an endogenous retrovirus or infection with a novel exogenous retrovirus.
A recent study published in Neurology found no significant association between increased physical activity and the risk of developing amyotrophic lateral sclerosis (ALS). However, it was discovered that higher leisure time physical activities before age 25 resulted in an earlier onset of the disease by seven years.
SourceAmerican Academy of Neurology·JournalNeurology·DateJan 24, 2005
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A large multi-center clinical trial is planned to test the safety and efficacy of antibiotics in treating ALS. Daily injections of ceftriaxone delayed nerve damage and extended survival by 10 days in mice with a Lou Gehrig's disease model.
SourceJohns Hopkins Medicine·JournalNature·DateJan 5, 2005
Researchers transplanted adult olfactory bulb stem cells into genetically engineered mice with ALS, showing a significant delay in disease symptoms and improved functional outcomes. The study suggests these stem cells may hold potential for treating ALS, but further laboratory work is needed.
Researchers have used human spinal cord cells to delay ALS symptoms in rats by 11 days. The study's findings suggest that neuronal stem cells may hold promise for treating conditions caused by separation within the nervous system.
Scientists have found that a longevity protein called SIRT1 delays the breakdown of axons in nerve cells, potentially slowing neurodegenerative diseases. The discovery opens new avenues for treating Parkinson's disease, Alzheimer's disease, and other disorders.
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
Mitochondrial damage is a key factor in Lou Gehrig's disease, causing cells to die. The study reveals that mutant SOD1 protein clogs the transport system of mitochondria in muscle-controlling nerve cells.
Researchers have discovered biomarkers for ALS in cerebrospinal fluid, which could enable rapid diagnosis and prompt treatment. These biomarkers have high sensitivity and specificity, and may be used to monitor drug effectiveness in clinical trials.
SourceFederation of American Societies for Experimental Biology·DateApr 18, 2004
A new gene mutation has been discovered for a rare form of inherited paralysis called hereditary spastic paraplegia. This breakthrough could lead to improved diagnosis and potential treatments for the condition, which affects around 20,000 Americans.
SourceMichigan Medicine - University of Michigan·JournalAmerican Journal of Human Genetics·DateSep 25, 2003
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
A study published in Neurology reveals that Gulf War veterans under 45 have developed ALS, a neurodegenerative disorder, at an alarming rate. The Department of Veterans Affairs confirms the findings using a different method, raising questions about environmental exposures during the war and potential links to Gulf War syndrome.
SourceUT Southwestern Medical Center·JournalNeurology·DateSep 22, 2003
Researchers found that injecting a gene producing insulin-like growth factor-1 (IGF-1) into muscles delayed disease onset by 31 days, preserved nerve cells, and reduced muscle wasting. This study may lead to a new, gene-based treatment for ALS affecting over 30,000 Americans.
Researchers at Johns Hopkins and Salk Institute develop gene therapy that slows progression of amyotrophic lateral sclerosis (ALS), a devastating disease affecting thousands. In experiments with mice, injection of insulin-like growth factor-1 (IGF-1) into muscles extends survival and improves strength.
SourceJohns Hopkins Medicine·JournalScience·DateAug 7, 2003
Researchers at Project A.L.S. have successfully tested a gene therapy approach that delays disease progression and prolongs survival in a mouse model of ALS. The treatment uses an adeno-associated viral vector to express the IGF1 protein, promoting neuronal survival.
SourceHarrington Communications·JournalScience·DateAug 7, 2003
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
A new three-year grant will help researchers better understand the causes and risk factors of ALS, a neurodegenerative disease that affects 30,000 people in the US. The study aims to investigate the link between a genetic mutation called Hfe and the onset and progression of ALS.
Researchers used 3D imaging to study ALS mutant proteins, finding they interact incorrectly and form toxic complexes that interfere with nerve cell function. The study supports two theories: oxidative damage from mutant SOD1 protein and aggregation of protein complexes.
SourceNIH/National Institute of Neurological Disorders and Stroke·JournalNature Structural & Molecular Biology·DateMay 18, 2003
Researchers have discovered a genetic link between specific mutations in the Dnchc1 gene and selective death of motor neurons, causing diseases like ALS. The study provides new insight into the pathogenetic mechanism underlying MND.
SourceIngenium Pharmaceuticals·JournalScience·DateMay 1, 2003
Researchers identified chromosomal abnormalities in 5.9% of ALS patients, suggesting a previously unknown risk factor for the disease. The study highlights the need for systematic genetic analysis of patients with ALS and other neurodegenerative diseases.
SourceAmerican Academy of Neurology·JournalNeurology·DateApr 21, 2003
Sky & Telescope Pocket Sky Atlas, 2nd Edition
Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.
Researchers discovered a gene, Hsp27, that protects mature nerve cells from death following injury. Delivering this gene via therapy may lead to new treatments for neurodegenerative diseases and nerve injuries.
SourceMassachusetts General Hospital·JournalNeuron·DateSep 25, 2002
Researchers have found that growth factors play a key role in regulating how embryonic nerve cells acquire the ability to process information. This study suggests possible avenues for treating damaged nerve cells and restoring their function.
Scientists have found a gene responsible for a rare form of hereditary spastic paraplegia, a condition that slowly robs children of their ability to walk. The discovery has opened the door to better diagnosis and treatment of the disorder, as well as insights into other spinal cord problems.
SourceMichigan Medicine - University of Michigan·JournalNature Genetics·DateOct 28, 2001
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
A second gene mutation for the inherited form of ALS has been discovered by Northwestern University researcher Teepu Siddique. The newly identified gene, alsin, is responsible for juvenile inherited ALS (ALS2), a rare and slowly progressive disease affecting young populations in North Africa and the Middle East.
SourceNorthwestern University·JournalNature Genetics·DateOct 3, 2001